Instagram story viewer> @shivtosh_k> Tagged

shivtosh_k

@shivtosh_k

undefined

POSTS STORIES REELS TAGGED

PMOD is often overlooked, but what does it really mean for women’s metabolic health?

On this episode of All About Her, I sit down with Shivtosh Kumar, Co-founder of Sugar.fit, and Dr. Chhavi Goyal Mehra to unpack PMOD, diabetes, obesity and the surprising connections between them.

With 1 in 5 women affected by PMOD and metabolic health becoming an increasing concern, what do these numbers really tell us?

Watch the full conversation on All About Her on our YouTube channel.

#SohaAliKhan #PMOD #AllAboutHer #hereforher #womenhealth

75

2

Ozempic and GLP-1s have become a major part of the conversation around weight loss and diabetes. But who are they actually meant for?

On this episode of All About Her, I sit down with Shivtosh Kumar, Co-founder of Sugar.fit, and Dr. Chhavi Goyal Mehra to understand how GLP-1 medications are being approached in India, who may benefit from them, and why they should not be treated as a quick fix for weight loss.

So, who is the right person to take Ozempic, and what should you know before considering it?

Watch the full conversation on All About Her on our YouTube channel.

#SohaAliKhan #AllAboutHer #Ozempic #hereforher

241

7

Diabetes is often called a silent killer, but what are the real reasons behind it?

On this episode of All About Her, I sit down with Shivtosh Kumar, Co-founder of Sugar.fit, and Dr. Chhavi Goyal Mehra to unpack diabetes, GLP-1s, Ozempic, weight loss and metabolic health.

What are the three biggest reasons behind diabetes? And can GLP-1s really change the way we approach it?

Watch the full conversation on All About Her on our YouTube channel.

#SohaAliKhan #AlllAboutHer #GLP1 #Ozempic

42

0

Can everyone take GLP-1 drugs? And are they really the answer to weight loss?

In my latest episode of All About Her, @allabouther_aah we’re talking about diabetes, metabolic health, insulin resistance, weight loss and, of course, the much-discussed GLP-1 medications. What exactly do they do, who are they meant for, who should avoid them, and how should they actually be used?

I’m joined by Shivtosh Kumar, Founder of Sugar.fit @weightloss.sugarfit who works at the intersection of technology, data and personalised metabolic care, and Dr. Chhavi Goyal Mehra, who helps us understand the medical science behind diabetes, insulin resistance, weight and GLP-1 therapies.

Together, we unpack the myths, the science and the bigger picture of metabolic health — because managing your health is about much more than just a number on the weighing scale.

The latest episode of All About Her, is now LIVE.

Watch the full episode on YouTube. Link in bio

#AllAboutHer #SohaAliKhan #hereforher #GLP1 #DiabetesReversal

658

11

GLP-1, Metabolic Health & Why a Holistic Approach Matters

GLP-1 medications have quickly become one of the biggest conversations in metabolic health.

But the conversation shouldn’t stop at medication.

In India, nearly 100 million people live with diabetes, 120–130 million are estimated to be pre-diabetic, and 230–240 million experience obesity.

So why is medication often stigmatized when it is used to treat conditions like diabetes, obesity, or high blood pressure?

The reality is that metabolic health requires more than a pill. Sustainable outcomes come from combining medical treatment with personalized guidance, lifestyle support, and continuous monitoring.

That’s why effective care should go beyond simply downloading an app and purchasing medication.

Every individual should first be assessed for eligibility. In this program, 30–40% of applicants are reportedly rejected each month, ensuring only eligible individuals are enrolled.

Those who qualify receive structured support from a multidisciplinary team of doctors, coaches, nutritionists, and psychologists—alongside medication.

The message is simple:

GLP-1 can be part of the solution. But sustainable metabolic health requires a complete care program—not medication in isolation.

@weightloss.sugarfit
@shivtosh_k

[ GLP-1, Metabolic Health, Diabetes, Obesity, Pre-diabetes, Weight Management, Lifestyle Modification, Personalized Healthcare, Holistic Treatment, Preventive Healthcare ]

3

1

Do you have to stay on GLP-1 forever?

In this conversation, @shivtosh_k and @mehra.chhavi of @weightloss.sugarfit fit break down what happens when you stop GLP-1 medications, whether the weight comes back, and why there’s no one-size-fits-all answer.

Watch the full episode on Humans of Bombay YouTube, link in bio! 🔗
.
.
.
.
.
.
.
.
.
.
(GLP-1, weight loss, obesity, diabetes, weight loss medication, health, healthcare, Sugar.fit, Shivtosh Kumar, Dr Chhavi Mehra, Karishma Mehta, Humans of Bombay, health podcast, weight management, lifestyle, preventive healthcare)

89

1

Are GLP-1s a quick fix—or the beginning of a better approach to treating obesity and diabetes?

GLP-1s have quickly become one of the biggest conversations in healthcare. But the real question is: is medicine alone enough?

If obesity and diabetes are diseases, shouldn’t treatment go beyond just a prescription?

Doctors, nutrition, lifestyle changes and ongoing support all have a role to play in achieving better and more sustainable health outcomes.

What do you think—medicine alone, or a complete health program?

@shivtosh_k @weightloss.sugarfit

#GLP1 #Healthcare #Obesity #Diabetes #HealthTech WeightLoss HealthcareInnovation

3

15

“GLP-1 se darr kyun? 💉📈 What’s really behind the fear of the world’s most talked-about weight-loss drugs?”

@weightloss.sugarfit @shivtosh_k

#GLP1 #WeightLoss #Health #BusinessMultiverse #Pharma Healthcare Ozempic Mounjaro Wegovy BusinessNews

3

0

Why is GLP-1 suddenly everywhere? GLP-1 medications have quickly become one of the biggest topics in weight loss and healthcare. But their growing popularity isn’t just about losing weight. These medicines can affect appetite, blood sugar regulation and how the body manages food intake.

At the same time, medication alone isn’t the whole picture. A sustainable approach may also involve proper nutrition, physical activity, medical guidance and mental well-being. Everyone responds differently, so GLP-1 medicines should be taken only with guidance from a qualified healthcare professional.

The real goal isn’t just losing weight, but building healthier habits that can last.
Featuring @weightloss.sugarfit and @shivtosh_k
Save this post to understand why GLP-1 is suddenly everywhere.

#GLP1 #GLP1Medication #WeightLoss

3

0

90 Million Indians Have Diabetes. In March, the Drug That Treats It Got 90% Cheaper.

@shivtosh_k
@weightloss.sugarfit

India has one of the largest diabetes burdens on Earth, roughly 10.5% of adults, about 90 million people. For years, the most effective new class of drugs for it sat far out of reach of almost all of them.

Here's what GLP-1 drugs actually do. GLP-1 is a hormone your gut releases after eating. It tells your pancreas to release insulin, tells your liver to stop dumping stored glucose into your blood, slows how fast your stomach empties, and signals your brain that you're full. In type 2 diabetes, that system underperforms. Drugs like semaglutide mimic the hormone, restoring the signal, which is why blood sugar control improves and appetite drops as a side effect.

The catch was always price. Ozempic and Wegovy ran ₹15,000 to ₹25,000 a month in India, impossible for the vast majority of patients who needed them. Novo Nordisk earned $17 billion from Ozempic and $8.4 billion from Wegovy in 2024 alone.

Then on March 20, 2026, semaglutide's Indian patent expired. What followed was one of the biggest pharma events in recent Indian history: over 50 branded generics launched almost immediately, from Dr. Reddy's, Cipla, Sun Pharma, Biocon, Lupin, and others. Prices dropped 70-90%. Monthly costs in some cases fell from around $92 to $53, and further still.

India supplies 20% of the world's generic drugs. This is the "pharmacy of the world" doing exactly what it's built to do, at home.

These remain prescription drugs requiring medical supervision, not something to self-start. But for millions, the barrier was never the science. It was the price tag.

#GLP1 #StartupUnboxing #IndianPharma #Diabetes #HealthcareIndia GenericDrugs PharmaBusiness IndianBusiness Semaglutide PublicHealth

3

0

GLP is everywhere right now but the real conversation goes beyond the medication.
For obesity management, the best outcomes come from a complete approach: medical supervision, better nutrition, lifestyle changes, coaching, and consistent support.

GLP can be a tool.
The transformation comes from the entire program around it.

@shivtosh_k @weightloss.sugarfit

.
.
.
.
.
.
#GLP1 #ObesityManagement #WeightLossJourney #LifestyleMedicine #HealthTalk Nutrition

3

16

Everyone’s talking about GLP-1, but beyond the hype lies a bigger conversation. From weight loss to wellness, what’s the real story behind the medicine everyone is discussing?

@weightloss.sugarfit @shivtosh_k

#GLP1 #HealthAndWellness #MarketingMedia

3

10